Elevated Monoamine Oxidase-A Binding in Borderline Personality Disorder: An [11C] Harmine Pet Study

被引:0
|
作者
Kolla, Nathan J. [1 ,2 ]
Wilson, Alan A. [1 ,2 ]
Houle, Sylvain [1 ,2 ]
Links, Paul [3 ]
McMain, Shelley [1 ]
Bagby, Michael [1 ]
Meyer, Jeffrey H. [1 ,2 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada
[3] Univ Western Ontario, London, ON, Canada
关键词
borderline personality disorder; monoamine oxidase-A; dysphoria; positron emission tomography; harmine;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
633
引用
收藏
页码:201S / 201S
页数:1
相关论文
共 50 条
  • [31] Imaging of monoamine oxidase-A in the human brain with [11C] befloxatone: quantification strategies and correlation with mRNA transcription maps
    Zanotti-Fregonara, Paolo
    Leroy, Claire
    Rizzo, Gaia
    Roumenov, Dimitri
    Trichard, Christian
    Martinot, Jean-Luc
    Bottlaender, Michel
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (12) : 1254 - 1261
  • [32] Elevated Monoamine Oxidase a Density In Severe and Atypical-Type Depression: A [C-11] Harmine Positron Emission Tomography Study
    Chiuccariello, Lina
    Houle, Sylvain
    Miler, Laura
    Cooke, Robert G.
    Levitan, Robert D.
    Kish, Stephen J.
    Wilson, Alan A.
    Rusjan, Pablo
    Meyer, Jeffrey H.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 182S - 182S
  • [33] Correction to: Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C] CURB positron emission tomography study
    Nathan J. Kolla
    R. Mizrahi
    K. Karas
    C. Wang
    R. M. Bagby
    S. McMain
    A. I. Simpson
    P. M. Rusjan
    R. Tyndale
    S. Houle
    I. Boileau
    Neuropsychopharmacology, 2021, 46 : 1393 - 1393
  • [34] MAPPING HUMAN-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B WITH C-11 LABELED SUICIDE INACTIVATORS AND PET
    FOWLER, JS
    MACGREGOR, RR
    WOLF, AP
    ARNETT, CD
    DEWEY, SL
    SCHLYER, D
    CHRISTMAN, D
    LOGAN, J
    SMITH, M
    SACHS, H
    AQUILONIUS, SM
    BJURLING, P
    HALLDIN, C
    HARTVIG, P
    LEENDERS, KL
    LUNDQVIST, H
    ORELAND, L
    STALNACKE, CG
    LANGSTROM, B
    SCIENCE, 1987, 235 (4787) : 481 - 485
  • [35] LOW PLATELET MONOAMINE-OXIDASE ACTIVITY IN BORDERLINE PERSONALITY-DISORDER
    YEHUDA, R
    SOUTHWICK, SM
    EDELL, WS
    GILLER, EL
    PSYCHIATRY RESEARCH, 1989, 30 (03) : 265 - 273
  • [36] Influence of a Low Dose of Amphetamine on Vesicular Monoamine Transporter Binding: A PET (+)[11C]DTBZ Study in Humans
    Boileau, Isabelle
    Houle, Sylvain
    Rusjan, Pablo M.
    Furukawa, Yoshiaki
    Wilkins, Diana
    Tong, Junchao
    Selby, Peter
    Wilson, Alan A.
    Kish, Stephen J.
    SYNAPSE, 2010, 64 (06) : 417 - 420
  • [37] Acute Effects of Stress Upon Prefrontal and Limbic MAO-A Binding in Healthy Humans: A [11C] harmine PET Study
    Soliman, Alexandra
    Pruessner, Jens
    Fan, Ian
    Xu, Cynthia
    Miler, Laura
    Sacher, Julia
    Rusjan, Pablo
    Houle, Sylvain
    Wilson, Alan
    Meyer, Jeffrey
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 176S - 176S
  • [38] Comparison of the binding of the irreversible monoamine oxidase tracers, [11C]clorgyline and [11C]l-deprenyl in brain and peripheral organs in humans
    Fowler, JS
    Logan, J
    Wang, GJ
    Volkow, ND
    Telang, F
    Ding, YS
    Shea, C
    Garza, V
    Xu, YW
    Li, ZH
    Alexoff, D
    Vaska, P
    Ferrieri, R
    Schlyer, D
    Zhu, W
    Gatley, SJ
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (03) : 313 - 319
  • [39] Role of Kappa Opioid Receptor Availability in Borderline Personality Disorder and Suicidal Behavior: Preliminary Results From an in Vivo [11C]EKAP PET Study
    Davis, Margaret
    Wilson, Olivia
    DeBonee, Sarah
    Nabulsi, Nabeel
    Matuskey, David
    Esterlis, Irina
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S169 - S170
  • [40] Corticostriatal Connectivity in Antisocial Personality Disorder by Monoamine Oxidase-A Genotype and its Relationship to Aggressive Behavior
    Kolla, Nathan
    Dunlop, Katharine
    Meyer, Jeffrey
    Downar, Jonathan
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S411 - S411